Association of Ambient Particulate Matter and Nitrogen Dioxide with Hospital Admissions for Parkinson's Disease: A Nationwide Case-Crossover Study in China.

Environ Pollut

Department of Occupational and Environmental Health, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China; Key Laboratory of Environment and Genes Related to Diseases (Xi'an Jiaotong University), Ministry of Education, Xi'an, China; Key Laboratory for Disea

Published: September 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Ambient particulate matter (PM) and nitrogen dioxide (NO) are both major air pollutants with potential neurotoxic effects. Beyond fine PM (PM), large population-based evidence on the associations of coarse PM (PM) and NO, especially co-exposure to high-concentration PM and NO, with hospital admissions for Parkinson's disease (PD) is crucial for PD risk management. In this time-stratified case-crossover study, patients with a principal discharge diagnosis coded of PD (G20) were identified. The associations of PM, PM and NO with increased admissions for PD were investigated based on hospital admissions data from the urban basic medical insurance schemes across 233 cities at or above the prefecture level in China during 2013-2017. A total of 293,357 hospital admissions were included in the study. An interquartile range increase in PM (34.5 μg/m), PM (20.2 μg/m) and NO (19.5 μg/m) at lag 01was associated with increases of 1.80% (95% confidence interval [CI], 0.71-2.90%), 2.93% (95% CI, 1.44-4.45%) and 4.67% (95% CI, 2.90-6.47%) in PD admissions, respectively. Only associations for PM and NO remained statistically significant after controlling for the other air pollutants and generalized propensity score. In comparison with low-concentration exposure (<30 percentile concentration), high-concentration exposures (≥60 percentile concentration) to PM and NO were both positively associated with increased PD admissions. Meanwhile, co-exposures to moderate and heavy exceedance of PM and NO were respectively associated with an increase of 4.61% (95% CI, 2.58-6.68%) and 9.72% (95% CI, 5.75-13.85%) in PD admissions, compared with within-standard co-exposure. This innovative exploration provided new epidemiological evidence that PM and NO may increase the risk of PD admissions independent of the other air pollutants, and co-exposure is likely associated with a more pronounced increase in PD admissions than separate exposure.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.envpol.2025.127062DOI Listing

Publication Analysis

Top Keywords

hospital admissions
16
ambient particulate
8
particulate matter
8
matter nitrogen
8
nitrogen dioxide
8
admissions parkinson's
8
parkinson's disease
8
case-crossover study
8
air pollutants
8
admissions
6

Similar Publications

Objectives: The risk of major venous thromboembolism (VTE) among patients with COVID-19 is high but varies with disease severity. Estimate the incidence of lower extremity deep venous thrombosis (DVT) in critically ill hospitalized patients with COVID-19, validate the Wells score for DVT diagnosis, and determine patients' prognosis.

Methods: This was an observational follow-up study in the context of the diagnosis and prognosis of DVT.

View Article and Find Full Text PDF

Background: Although splenomegaly is a common finding in Epstein-Barr virus (EBV) infection, splenic infarction is rarely reported and may be under-recognised, especially in adults. Neurological complications such as aseptic meningitis are also uncommon but documented. The simultaneous occurrence of both complications in the context of primary EBV infection is exceptional.

View Article and Find Full Text PDF

Introduction: Primary central nervous system vasculitis (primary CNS vasculitis) is a rare inflammatory disorder that affects small-to-medium-sized cerebral vessels, often leading to recurrent strokes. Diagnosis is vague due to non-specific neurological symptoms. Imaging findings, cerebrospinal fluid (CSF) analysis and exclusion of systemic vasculitis are essential for diagnosis.

View Article and Find Full Text PDF

Predictors of mortality and hospitalised exacerbations in obstructive airway diseases.

ERJ Open Res

September 2025

Department of Bioanalysis, Pharmaceutical Care Unit, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium.

Background: In Belgium, age-standardised hospital admission and mortality rates for asthma and COPD are higher than the European average. Understanding the factors that lead to a hospitalised exacerbation and/or mortality is needed to optimise patient management.

Methods: Patients ≥18 years old obtaining two claims for drugs for obstructive airway diseases (ATC code R03) in 1 year between 2017 and 2022 were identified in Belgian nationwide claims-based data.

View Article and Find Full Text PDF

Impact of personalized nursing on the quality of life in lung cancer patients.

Front Oncol

August 2025

Health Management Department, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Background: Lung cancer remains a leading cause of cancer-related morbidity and mortality worldwide. As systemic therapy prolongs survival, improving patients' quality of life (QoL) has become a central goal of holistic care. Personalized nursing interventions, tailored to individual patient needs, have shown promise in oncology but lack large-scale evaluation in lung cancer populations.

View Article and Find Full Text PDF